NUE

Nucor (NUE) – An Underrated Stock with Hidden Potential?

Nucor may be undervalued with mixed growth prospects, but the 9 analysts following the company give it an rating of hold. Their target prices range from $39.0 to $210.0 per share, for an average of $168.33. At today's price of $187.28, Nucor is trading 11.26% away from its average target price, suggesting there is an analyst belief that shares are overpriced for the stock.

Nucor Corporation engages in manufacture and sale of steel and steel products. The large-cap Industrials company is based in Charlotte, NC. Nucor has provided a 1.1% dividend yield over the last 12 months.

Nucor has a trailing twelve month P/E ratio of 10.4, compared to an average of 22.19 for the Industrials sector. Considering its EPS guidance of $12.34, the company has a forward P/E ratio of 15.2.

Furthermore, the market is potentially undervaluing Nucor in terms of its book value because its P/B ratio is 2.21. In comparison, the sector average P/B ratio is 4.06. The company's shares are currently 2.0% below their Graham number, indicating that its shares have a margin of safety.

2018 2019 2020 2021 2022 2023
Revenue (MM) $25,067 $22,589 $20,140 $36,484 $41,512 $35,733
Revenue Growth n/a -9.89% -10.84% 81.15% 13.78% -13.92%
Operating Margins 13% 8% 4% 25% 25% 19%
Net Margins 9% 6% 4% 19% 18% 14%
Net Income (MM) $2,361 $1,271 $721 $6,827 $7,607 $4,995
Net Interest Expense (MM) $161 $157 $167 $163 $219 $243
Depreciation & Amort. (MM) $631 $649 $702 $735 $827 $898
Earnings Per Share $7.42 $4.14 $2.36 $23.16 $28.79 $19.72
EPS Growth n/a -44.2% -43.0% 881.36% 24.31% -31.5%
Diluted Shares (MM) 317 306 303 293 263 249
Free Cash Flow (MM) $1,411 $1,332 $1,154 $4,609 $8,124 $6,111
Capital Expenditures (MM) $983 $1,477 $1,543 $1,622 $1,948 $2,014
Current Ratio 3.08 3.34 3.61 2.48 3.39 3.72
Total Debt (MM) $4,291 $4,321 $5,283 $5,577 $6,642 $6,621
Net Debt / EBITDA 0.75 1.15 1.72 0.32 0.21 0.1
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS